Genetic risk tool could aid early diagnosis and treatment of multiple sclerosis patients

A new genetic risk tool could help diagnose multiple sclerosis (MS) earlier in young adults with optic neuritis, potentially preventing blindness. Optic neuritis is often a precursor to MS, and early treatment could improve long-term health outcomes. Research combining genetic risk for MS with demographic factors has shown promise in predicting MS risk in individuals…

Read More

Baby Development Stages: The First Year

Babies undergo incredible transformation in the first year of life, reaching important developmental milestones at their own pace. The first three months are characterized by smiling, head control, and hand-eye coordination. Between 4 and 6 months, babies start babbling, laughing, and reaching for objects. The next stage, from 7 to 9 months, sees babies crawling,…

Read More

Health Bulletin 28/ February/ 2024

This health bulletin from February 28, 2024, states that cookies are used on the website for analytics, advertising, and site improvement. By continuing to use the site, users agree to the use of cookies. More information can be found in the Cookie Policy and Cookie Settings. Source link

Read More

Janux Rides Its TRACTr to Validation in Prostate Cancer and More Solid Tumors

Janux Therapeutics is developing T cell engagers to treat tumors, with promising Phase 1 data showing potential for blockbuster success. Their technology, TRACTr, aims to overcome limitations of current therapies by reducing toxicity and increasing efficacy. Their lead program, JANX007, has shown positive results in treating prostate cancer, with significant declines in PSA levels without…

Read More

Serum Ferritin Levels May Predict Long-Term Outcomes in MASLD

A study published in Gut found that serum ferritin levels may help predict the long-term prognosis of metabolic dysfunction-associated steatotic liver disease (MASLD). The study, conducted at multiple sites, showed that patients with high serum ferritin levels were at higher risk for extrahepatic cancer, liver-related events, hepatocellular carcinoma, and mortality compared to those with normal-low…

Read More

b.well Connected Health scores $40M to accelerate growth

b.well Connected Health, a health management platform, closed a $40 million Series C growth round led by Leavitt Equity Partners. They focus on unifying patients’ health records and financial information, while also integrating wearable data and other healthcare information. The platform offers interoperability and personalization at scale, allowing clients to earn rewards through a gamified…

Read More
error: Content is protected !!